Condition: Acute Myeloid Leukemia · Sponsor: University of Ulm
A Randomized, Placebo-Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2
This description comes directly from the study's public registry record.
Hartmut Doehner, MD · 004973150045501 · harmut.doehner@uniklinik-ulm.de
Always discuss trial participation with your own doctor first.
| Tirol Kliniken GmbH | Innsbruck, Austria | Not Yet Recruiting |
| Kepler Universitaetsklinikum GmbH | Linz, Austria | Not Yet Recruiting |
| Ordensklinikum Linz GmbH | Linz, Austria | Not Yet Recruiting |
| Landeskrankenhaus (LKH) Rankweil, Interne E am Landeskrankenhaus Rankweil | Rankweil, Austria | Not Yet Recruiting |
| Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH | Salzburg, Austria | Not Yet Recruiting |
| Hanusch Krankenhaus Der Wiener Gebietskrankenkasse | Vienna, Austria | Recruiting |
| Ziekenhuis Aan De Stroom | Antwerp, Belgium | Not Yet Recruiting |
| Az St-Jan Brugge-Oostende A.V. | Bruges, Belgium | Not Yet Recruiting |
| Universitair Ziekenhuis Brussel | Brussels, Belgium | Recruiting |
| Katholieke Universiteit te Leuven | Leuven, Belgium | Not Yet Recruiting |
| Algemeen Ziekenhuis Delta | Roeselare, Belgium | Recruiting |
| CHU UCL NAMUR - Mont Godinne | Yvoir, Belgium | Recruiting |
+ 79 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04628026